BlackRock Health Sciences Trust (NYSE:BME) Stock Crosses Above 50-Day Moving Average – What’s Next?

BlackRock Health Sciences Trust (NYSE:BME)’s share price passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $39.39 and traded as high as $40.77. BlackRock Health Sciences Trust shares last traded at $40.3320, with a volume of 49,467 shares changing hands.

BlackRock Health Sciences Trust Stock Down 0.4%

The company’s fifty day simple moving average is $39.39 and its two-hundred day simple moving average is $40.55.

BlackRock Health Sciences Trust Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th will be issued a dividend of $0.2621 per share. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a c) annualized dividend and a dividend yield of 7.8%.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. increased its holdings in shares of BlackRock Health Sciences Trust by 22.2% during the third quarter. Northwestern Mutual Wealth Management Co. now owns 1,417 shares of the company’s stock worth $53,000 after purchasing an additional 257 shares during the period. AlphaStar Capital Management LLC increased its holdings in shares of BlackRock Health Sciences Trust by 2.2% during the fourth quarter. AlphaStar Capital Management LLC now owns 12,099 shares of the company’s stock worth $498,000 after purchasing an additional 258 shares during the period. PMG Family Office LLC increased its holdings in shares of BlackRock Health Sciences Trust by 4.1% during the first quarter. PMG Family Office LLC now owns 6,705 shares of the company’s stock worth $258,000 after purchasing an additional 263 shares during the period. Oppenheimer & Co. Inc. increased its holdings in shares of BlackRock Health Sciences Trust by 5.9% during the third quarter. Oppenheimer & Co. Inc. now owns 6,715 shares of the company’s stock worth $250,000 after purchasing an additional 373 shares during the period. Finally, HBK Sorce Advisory LLC increased its holdings in shares of BlackRock Health Sciences Trust by 3.8% during the fourth quarter. HBK Sorce Advisory LLC now owns 13,160 shares of the company’s stock worth $554,000 after purchasing an additional 476 shares during the period.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.